Procurement intelligence

Federal contract award

B+4 CPT CLINICAL IMMUNOHISTOCHEMISTRY AND IN-SITU HYBRIDIZATION

ROCHE DIAGNOSTICS CORPORATION · Department of Veterans Affairs

Value: $120,976
Start: Apr 1, 2026
End: Mar 31, 2027
Action date: Mar 11, 2026
PIID: 36C26126P0448
Status: active
NAICS: 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Place of performance: INDIANAPOLIS, IN
Award type: PURCHASE ORDER

Description

B+4 CPT CLINICAL IMMUNOHISTOCHEMISTRY AND IN-SITU HYBRIDIZATION

Need modifications, related awards, and vendor peers? Open the full award workspace.